Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion description "[Using the HER-2/neu oncogenic protein as a model, a well-defined tumor antigen in breast cancer, we questioned whether patients with advanced stage HER-2/neu overexpressing breast and ovarian cancers (III/IV) had evidence of pre-existent immunity to HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion evidence source_evidence_literature NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion SIO_000772 11072789 NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion wasDerivedFrom befree-20150227 NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_assertion wasGeneratedBy ECO_0000203 NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.
- befree-20150227 importedOn "2015-02-27" NP991695.RASdLnWmZ_OiG0vgT0Ob-uNp1IjbE9nBB0TQmJw_sIGug130_provenance.